Turning Point Therapeutics 2
Pharma & Biotech company headquartered in San Diego, CA. Cross-border supply chain, facility locations, and freight intelligence below.
Turning Point Therapeutics next-gen kinase inhibitor developer; repotrectinib acquired by BMS.
- Industry
- Pharma & Biotech
- Headquarters
- San Diego, CA
- US facilities
- San Diego, CA
Start a free trial to see Turning Point Therapeutics 2’s full freight profile — facility network, cross-border lanes, and shipper intelligence.